Sigue la actividad de operaciones con información privilegiada más reciente de AnaptysBio. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de AnaptysBio.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
En AnaptysBio Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de - acciones por valor de -, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Aug 12, 2025 | — | 0.00 | $13.27 | -$129.81K | SELL-OPTIONS | 0.00% | 4.96K | Aug 08 | ||
Jul 03, 2025 | — | 0.00 | $15.25 | -$348.18K | SELL-OPTIONS | 0.00% | 4.96K | Jul 02 | ||
Jun 20, 2025 | — | -3.02K | $23.97 | -$72.27K | SELL | -37.78% | 4.96K | Jun 18 | ||
Jun 20, 2025 | — | -3.02K | $23.97 | -$72.27K | SELL | -37.78% | 4.96K | Jun 18 | ||
Jan 02, 2025 | DIRECTOR | 85.10K | $12.92 | $1.10M | BUY | 1.09% | 7.88M | Dec 30 - Jan 02 | ||
Dec 03, 2024 | — | 0.00 | $15.96 | -$180.70K | SELL-OPTIONS | 0.00% | 1.95K | Nov 29 | ||
Sep 24, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $28.59 | -$30.25K | SELL-OPTIONS | 0.00% | 15.40K | Sep 23 | ||
Sep 17, 2024 | CHIEF LEGAL OFFICER | -1.50K | $26.71 | -$422.36K | SELL | -31.65% | 3.24K | Sep 14 - Sep 17 | ||
Sep 17, 2024 | CHIEF MEDICAL OFFICER | 3.78K | $38.93 | -$86.42K | SELL-OPTIONS | 32.54% | 15.40K | Sep 14 - Sep 16 | ||
Sep 17, 2024 | CHIEF FINANCIAL OFFICER | 3.78K | $30.04 | -$286.12K | SELL-OPTIONS | 392.12% | 4.74K | Sep 14 - Sep 16 | ||
Aug 16, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $29.25 | -$43.00K | SELL-OPTIONS | 0.00% | 11.62K | Aug 14 | ||
Aug 16, 2024 | 10% OWNER | 273.97K | $36.50 | $10.00M | BUY | 3.64% | 7.79M | Aug 14 | ||
Jul 19, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $26.75 | -$24.75K | SELL-OPTIONS | 0.00% | 11.62K | Jul 18 | ||
Jul 17, 2024 | — | 0.00 | $18.79 | -$237.12K | SELL-OPTIONS | 0.00% | 1.95K | Jul 15 | ||
Jun 24, 2024 | — | -1.95K | $23.17 | -$45.18K | SELL | -50.00% | 1.95K | Jun 21 | ||
Jun 18, 2024 | — | 1.95K | $23.16 | -$45.16K | SELL-OPTIONS | ∞ | 1.95K | Jun 15 - Jun 18 | ||
May 24, 2024 | CHIEF FINANCIAL OFFICER | -1.50K | $23.72 | -$35.58K | SELL | -60.88% | 964.00 | May 22 | ||
Mar 26, 2024 | CEO | -496.38K | $21.95 | -$10.89M | SELL | -55.27% | 401.65K | Mar 22 - Mar 26 | ||
Feb 21, 2024 | CHIEF LEGAL OFFICER | 0.00 | $19.51 | -$54.90K | SELL-OPTIONS | 0.00% | 3.24K | Feb 16 | ||
Feb 01, 2024 | CHIEF FINANCIAL OFFICER | -3.06K | $23.63 | -$72.43K | SELL | -76.07% | 964.00 | Jan 30 | ||
Jan 09, 2024 | CHIEF MEDICAL OFFICER | 3.59K | $21.81 | -$55.70K | SELL-OPTIONS | 55.02% | 10.12K | Jan 06 - Jan 08 | ||
Jan 09, 2024 | CHIEF LEGAL OFFICER | 3.24K | $21.81 | -$50.27K | SELL-OPTIONS | ∞ | 3.24K | Jan 06 - Jan 08 | ||
Jan 09, 2024 | CHIEF FINANCIAL OFFICER | 3.06K | $21.81 | -$47.55K | SELL-OPTIONS | 317.95% | 4.03K | Jan 06 - Jan 08 | ||
Jan 09, 2024 | CEO | 10.98K | $21.81 | -$149.75K | SELL-OPTIONS | 1.24% | 898.03K | Jan 06 - Jan 08 | ||
Nov 27, 2023 | CHIEF LEGAL OFFICER | -882.00 | $14.19 | -$12.52K | SELL | -100.00% | 0.00 | Nov 22 | ||
Sep 18, 2023 | CHIEF MEDICAL OFFICER | 3.90K | $19.48 | -$41.01K | SELL-OPTIONS | 147.99% | 6.53K | Sep 14 | ||
Sep 18, 2023 | CHIEF LEGAL OFFICER | 0.00 | $19.37 | -$116.24K | SELL-OPTIONS | 0.00% | 882.00 | Sep 14 - Sep 18 | ||
Sep 18, 2023 | CHIEF FINANCIAL OFFICER | 0.00 | $19.37 | -$116.24K | SELL-OPTIONS | 0.00% | 964.00 | Sep 14 - Sep 18 | ||
Aug 09, 2022 | COO, GENERAL COUNSEL | -523.00 | $25.00 | -$13.07K | SELL | -100.00% | 0.00 | Aug 08 | ||
Jun 10, 2022 | COO, GENERAL COUNSEL | 0.00 | $19.01 | -$24.95K | SELL-OPTIONS | 0.00% | 523.00 | Jun 08 | ||
May 20, 2022 | COO, GENERAL COUNSEL | -1.15K | $20.50 | -$23.49K | SELL | -68.66% | 523.00 | May 18 | ||
May 09, 2022 | DIRECTOR | 0.00 | $21.63 | $0.00 | p / s | 0.00% | 7.52M | May 05 | ||
Dec 22, 2021 | PRESIDENT, CEO | 0.00 | $18.35 | -$1.26M | SELL-OPTIONS | 0.00% | 68.60K | Dec 20 | ||
Nov 05, 2021 | PRESIDENT, CEO | 0.00 | $18.06 | -$689.83K | SELL-OPTIONS | 0.00% | 67.64K | Nov 04 - Nov 05 | ||
Nov 05, 2021 | COO, GENERAL COUNSEL | 0.00 | $26.05 | -$89.55K | SELL-OPTIONS | 0.00% | 0.00 | Nov 04 | ||
Nov 02, 2021 | PRESIDENT, CEO | 0.00 | $16.72 | -$1.14M | SELL-OPTIONS | 0.00% | 67.64K | Nov 01 | ||
Oct 28, 2021 | PRESIDENT, CEO | 0.00 | $15.56 | -$461.88K | SELL-OPTIONS | 0.00% | 67.64K | Oct 26 | ||
May 04, 2021 | DIRECTOR | 221.50K | $23.24 | $5.15M | BUY | 3.03% | 7.52M | Apr 30 - May 04 | ||
Apr 27, 2021 | DIRECTOR | 147.30K | $23.63 | $3.48M | BUY | 2.06% | 7.30M | Apr 23 - Apr 27 | ||
Mar 10, 2021 | 10% OWNER | 3.31M | $18.93 | $62.62M | BUY | 86.10% | 7.15M | Mar 08 - Mar 09 | ||
Feb 25, 2021 | 10% OWNER | 29.50K | $25.48 | $751.66K | BUY | 0.77% | 3.84M | Feb 23 | ||
Feb 12, 2021 | COO, GENERAL COUNSEL | 0.00 | $24.51 | -$209.80K | SELL-OPTIONS | 0.00% | 0.00 | Feb 12 |
Explora operaciones con información privilegiada sobre todos los valores.